GB201406033D0 - Methods and materials relating to auto-immune disease - Google Patents
Methods and materials relating to auto-immune diseaseInfo
- Publication number
- GB201406033D0 GB201406033D0 GBGB1406033.9A GB201406033A GB201406033D0 GB 201406033 D0 GB201406033 D0 GB 201406033D0 GB 201406033 A GB201406033 A GB 201406033A GB 201406033 D0 GB201406033 D0 GB 201406033D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- auto
- methods
- immune disease
- materials relating
- relating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1406033.9A GB201406033D0 (en) | 2014-04-03 | 2014-04-03 | Methods and materials relating to auto-immune disease |
PCT/GB2015/051030 WO2015150815A1 (en) | 2014-04-03 | 2015-04-01 | Methods and materials relating to auto-immune disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1406033.9A GB201406033D0 (en) | 2014-04-03 | 2014-04-03 | Methods and materials relating to auto-immune disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201406033D0 true GB201406033D0 (en) | 2014-05-21 |
Family
ID=50776785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1406033.9A Ceased GB201406033D0 (en) | 2014-04-03 | 2014-04-03 | Methods and materials relating to auto-immune disease |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201406033D0 (en) |
WO (1) | WO2015150815A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019390483A1 (en) * | 2018-11-30 | 2021-07-15 | Aleta Biotherapeutics Inc. | Single domain antibodies against CLL-1 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2526284C (en) * | 2003-06-25 | 2014-11-18 | Crucell Holland B.V. | Binding molecules for the treatment of myeloid cell malignancies |
US20060171929A1 (en) * | 2005-01-31 | 2006-08-03 | The University Of Washington | Regulation of dendritic cell functions by the DCAL-2 receptor |
-
2014
- 2014-04-03 GB GBGB1406033.9A patent/GB201406033D0/en not_active Ceased
-
2015
- 2015-04-01 WO PCT/GB2015/051030 patent/WO2015150815A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015150815A1 (en) | 2015-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285287A (en) | Antibodies to tigit | |
HK1255067A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
HK1243440A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
IL246661A0 (en) | Human antibodies to pd-l1 | |
IL247407B (en) | Anti-egfrviii antibodies and uses thereof | |
GB201519858D0 (en) | Therapeutic combinations comprising anti-CD73 antibodies and uses thereof | |
ZA201703443B (en) | Oral rehydration composition and methods thereof | |
GB201404470D0 (en) | Therapeutic methods and materials | |
IL247315B (en) | Anti-acth antibodies and use thereof | |
IL251001B (en) | Anti-il-25 antibodies and uses thereof | |
PT3101132T (en) | Anti-transthyretin human antibody | |
PL3180356T3 (en) | Human anti-fgfr4 antibody | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
GB201406033D0 (en) | Methods and materials relating to auto-immune disease | |
GB2530075B (en) | Improvements in and relating to eyewashing | |
GB201519421D0 (en) | Methods and apparatuses relating to injection-moulded objects | |
GB201419239D0 (en) | Methods and apparatus relating to injection-moulded objects | |
GB201409548D0 (en) | Methods and apparatuses relating to injection-moulded objects | |
GB201417432D0 (en) | Improvements in and relating to pipe-breaking | |
GB201413266D0 (en) | Improvements in or relating to nethergarment construction | |
GB201410990D0 (en) | General cure to diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |